In vitro: PCZ exhibits a synergistic effect on cancer cell death, both in vitro and in xenograft models, and improves the overall survival of mice (59).In vivo: alters EGFR distribution, reversibly inhibit the endocytosis of membrane proteins targeted by therapeutic monoclonal antibodies (58). The gene discussed is EGFR; the disease is cancer.